A Norman cyclist who has lived with multiple sclerosis for nearly two decades is riding coast-to-coast to raise awareness and ...

A new study reveals how Epstein-Barr virus may provoke immune cells to attack the brain, offering fresh hope for treating multiple sclerosis.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

Cerebrospinal fluid (CSF)-based molecular tests can reliably distinguish multiple sclerosis (MS) from other neurological ...

People typically develop multiple sclerosis between ages 20 and 40, but late-onset MS affects those 50 years and older. Your doctor can best diagnose and advise on possible treatments, such as ...

Multiple sclerosis is an autoimmune condition where, for reasons scientists are still trying to understand, your body’s immune system suddenly attacks the coating covering the nerves in your brain and ...

Multiple sclerosis is a central nervous system autoimmune condition that damages myelin sheath that protects the nervous system, affects brain and spinal cord and leads to aggravated conditions like ...

Multiple sclerosis (MS) is a chronic disease that affects your brain and spinal cord. When you have it, your immune system -- your body's defense against germs -- attacks the insulation, or myelin, ...

Severity of multiple sclerosis (MS) was linked with geographic latitude, an observational study showed. Among 46,000 MS patients living in temperate zones, more severe disease was seen in those who ...